The probable auto-antigenic role of lipids (Anti-ganglioside antibodies) in the pathogenesis of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 42, Issue , 2014, Pages S163-S166

  Koutsouraki, Euphrosyni ^a   Hatzifilippou, Eleni ^a   Michmizos, Dimitrios ^a   Banaki, Tania ^a   Costa, Vassiliki ^a   Baloyannis, Stavros ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Alzheimer's disease; dementia; gangliosides; lipids

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1B ANTIBODY; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GQ 1B ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG; ANTI-IGM; ANTIIDIOTYPIC ANTIBODY; GANGLIOSIDE; GQ1B GANGLIOSIDE;

AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGENICITY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PATHOGENESIS; BLOOD; IMMUNOLOGY; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIBODIES, ANTI-IDIOTYPIC; FEMALE; GANGLIOSIDES; HUMANS; MALE; MIDDLE AGED;

EID: 84920594463     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132633     Document Type: Conference Paper

References (16)

1. Jovanovic V, Abdul Aziz N, Lim YT, Ng Ai Poh A, Jin Hui Chan S, Ho Xin Pei E, LewFC, Shui G, Jenner AM, Bowen L, McKinneyEF,Lyons PA,KemenyMD, Smith KG,WenkMR, Macary PA (2013) Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus. PLoS One 8, e55639.
2. Sardi F, Fassina L, Venturini L, Guirrerro F, Rolfo E, Ricevuti G (2011) Alzhemire's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun Rev 11, 149-153.
3. Yu RK (1994) Development regulation of ganglioside metabolism. Prog Brain Res 101, 31-44.
4. Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK (1997) Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 272, 22987-22990.
5. Colasanti T, Barbati C, Rosano G, Malorni W, Ortona E (2010) Autoantibodies in patients with Alzheimer's disease: Pathogenic role and potential use as biomarkers of disease progression. Autoimmun Rev 9, 807-811.
6. Ariga K, Hill JP, Lee MV, Vinu A, Charvet R, Acharya S (2008) Challenges and breakthroughs in recent research on self-assembly. Sci Technol Adv Mate 9, 014109.
7. Chapman MJ, Sela B-A,Wertman E, Michaelson DM (1988) Antibodies to gangliosides GM1 in patients with Alzheimer's disease. Neurosci Lett 86, 235-240.
8. Mosek A, Yust I, Treves TA, Vardinon N, Korczyn AD, Chapman J (2005) Dementia and antiphospholipid antibodies. Dement Geriatr Cogn Disord 11, 36-38.
9. Ariga T1, Kubota M, Nakane M, Oguro K, Yu RK, Ando S (2013) Anti-Chol-1 antigen, GQ1b-, antibodies are associated with Alzheimer's disease. PLoS One 8, e63326.
10. Weksler ME, Szabo P, Relkin NR, Reidenberg MM, Weksler BB, Coppus AM (2013) Alzheimer's disease and Down syndrome: Treating two paths to dementia. Autoimmun Rev 12, 670-673.
11. Hatzifilippou E,Koutsouraki E, BanakiT,Traka M, CostaVG, Baloyannis SJ (2008) Antibodies against GM1 in demented patients. Am J Alzheimers Dis Other Demen 23, 274-279.
12. Foley P, Bradford HF, Docherty M, Fillit H, Luine VN, McEwen B, Bucht G, Winblad B, Hardy J (1988) Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease. J Neurol 235, 466-471.
13. Kuwabara S, Ogawara K, Mizobuchi K, Koga M, Mori M, Hattori T, Yuki N (2000) Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barre syndrome with antiganglioside antibodies. J Neurol Neurosurg Psychiatry 68, 191-195.
14. Ravindranath MH, Muthugounder S, Saravanan TS, Presser N, Morton DL (2005) Human antiganglioside autoantibodies: Validation of ELISA. Ann N Y Acad Sci 1050, 229-242.
15. Huflejt ME, Vuskovic M, Vasiliu D, Xu H, Obukhova P, Shilova N, Tuzikov A, Galanina O, Arun B, Lu K, Bovin N (2009) Anti-carbohydrate antibodies of normal sera: Findings, surprises and challenges. Mol Immunol 46, 3037-3049.
16. Sadatipour BT, Greer JM, Pender MP (1998) Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann Neurol 44, 980-983.